Evidence map›Paper›PMID 35054237›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Differences between [

Ewa Burchardt, Zaneta Warenczak-Florczak, Paulina Cegła, Adam Piotrowski, Zefiryn Cybulski, Wojciech Burchardt, Andrzej Roszak, Witold Cholewiński

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ewa BurchardtDepartment of Radiotherapy and Oncological Gynecology, Greater Poland Cancer Center, 61-866 Poznan, Poland.ORCID 0000-0003-0497-637X
Zaneta Warenczak-FlorczakDepartment of Radiotherapy and Oncological Gynecology, Greater Poland Cancer Center, 61-866 Poznan, Poland.
Paulina CegłaDepartment of Nuclear Medicine, Greater Poland Cancer Center, 61-866 Poznan, Poland.ORCID 0000-0002-6676-3436
Adam PiotrowskiFaculty of Physics, Adam Mickiewicz University, 61-614 Poznan, Poland.ORCID 0000-0001-9379-7300
Zefiryn CybulskiGreater Poland Cancer Center, Microbiology Laboratorium, 61-866 Poznan, Poland.
Wojciech BurchardtDepartment of Electroradiology, University of Medical Science Poznan, 61-866 Poznan, Poland.ORCID 0000-0002-0013-8881
Andrzej RoszakDepartment of Radiotherapy and Oncological Gynecology, Greater Poland Cancer Center, 61-866 Poznan, Poland.ORCID 0000-0002-7263-1261
Witold CholewińskiDepartment of Electroradiology, University of Medical Science Poznan, 61-866 Poznan, Poland.
Poznan University of Medical Sciences · PLGreater Poland Cancer Center · PLAdam Mickiewicz University in Poznań · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to investigate if vaginal bacteriology obtained prior to treatment influences the 3'-deoxy-3 18F-fluorothymidine (FLT) [

methodsRetrospective analysis was performed on 39 women with locally advanced histologically confirmed cervical cancer who underwent dual tracer PET/CT examinations. The [

resultsIn the vaginal and/or cervical smears, there were 27 (79.4%) positive results. In seven (20.6%) cases, no opportunistic pathogen growth was observed (No Bacteria Group). In positive bacteriology, eleven (32%) Gram-negative bacilli (Bacteria group 2) and fifteen (44%) Gram-positive bacteria (Bacteria group 1) were detected. Five patients with unknown results were excluded from the analysis. Data analysis shows a statistically significant difference between the SUV

conclusionsThe lowest values of SUV

Indexed as

18F-fluoro-d-glucose ([18F]FDG)18F-fluorothymidine ([18F]FLT)cervical cancerpositron emission tomography computed tomographyvaginal bacteriology

Identifiers

PMID35054237
PMCPMC8774914
OpenAlexW4200595842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.